罗仁仙


【摘要】 目的:評价氟西汀治疗冠心病伴发抑郁症的效果。方法:选取2020年2-12月本院收治的88例冠心病伴发抑郁症患者,根据用药方案不同,将患者分为对照组和观察组,每组44例。对照组进行常规治疗,观察组在对照组的基础上加用氟西汀治疗。比较两组CRP水平、抑郁评分、生活质量评分、心血管不良事件、治疗效果。结果:治疗前,两组CRP水平、SDS评分比较,差异均无统计学意义(P>0.05);治疗后,两组CRP水平、SDS评分均低于治疗前,且观察组均低于对照组,差异均有统计学意义(P<0.05)。治疗前,两组疾病认知程度、治疗满意程度、心绞痛发作情况、心绞痛稳定状态、躯体活动受限程度评分、生活质量总分比较,差异均无统计学意义(P>0.05);治疗后,两组疾病认知程度、治疗满意程度、心绞痛发作情况、心绞痛稳定状态、躯体活动受限程度评分、生活质量总分均高于治疗前,且观察组均高于对照组,差异均有统计学意义(P<0.05)。观察组心血管不良事件发生率为4.55%,低于对照组的20.45%,观察组总有效率为97.73%,高于对照组的79.55%,差异均有统计学意义(P<0.05)。结论:在冠心病伴发抑郁症治疗中应用氟西汀,可以较好地改善患者疾病症状,减轻炎症,预防心血管不良事件,提高生活质量,疗效确切。
【关键词】 冠心病 抑郁症 氟西汀
Evaluation of Fluoxetine in the Treatment of Coronary Heart Disease with Depression/LUO Renxian. //Medical Innovation of China, 2021, 18(30): -134
[Abstract] Objective: To evaluate the effect of Fluoxetine in the treatment of coronary heart disease with depression. Method: A total of 88 patients with coronary heart disease complicated with depression admitted to our hospital from February to December 2020 were selected, and they were divided into control group and observation group according to different medication regimen, 44 cases in each group. The control group received routine treatment, and the observation group was treated with Fluoxetine on the basis of the control group. CRP level, depression score, quality of life score, cardiovascular adverse events and treatment effect were compared between two groups. Result: Before treatment, there were no significant differences in CRP level and SDS score between two groups (P>0.05); after treatment, CRP levels and SDS scores in both groups were lower than those before treatment, and those in the observation group were lower than those in the control group, the differences were statistically significant (P<0.05). Before treatment, there were no significant differences in disease cognition degree, treatment satisfaction degree, angina attack, stable state of angina pectoris, physical activity limitation degree scores and total score of quality of life between two groups (P>0.05); after treatment, the disease cognition degree, treatment satisfaction degree, angina pectoris attack, stable state of angina pectoris, physical activity limitation degree scores and total scores of quality of life in both groups were higher than those before treatment, and those in the observation group were higher than those in the control group, the differences were statistically significant (P<0.05). The incidence of adverse cardiovascular events in the observation group was 4.55%, which was lower than 20.45% in the control group, and the total effective rate in the observation group was 97.73%, which was higher than 79.55% in the control group, the differences were statistically significant (P<0.05). Conclusion: The application of Fluoxetine in the treatment of coronary heart disease with depression can better improve patients’ disease symptoms, reduce inflammation, prevent cardiovascular adverse events and improve the quality of life.
[Key words] Coronary heart disease Depression Fluoxetine
First-author’s address: Third Hospital of Longyan City, Longyan 364000, China
doi:10.3969/j.issn.1674-4985.2021.30.031
冠心病、高血压、糖尿病属于中老年人三大疾病,其中冠心病是发病率非常高的一种心血管疾病,近些年发病率、死亡率都有一定升高,严重损害患者的身心健康[1]。临床目前比较注重疾病的药物治疗和非药物预防干预,以及吸烟、高血压、高脂血症等冠心病危险因素的干预,但在抑郁症方面未得到关注。……